SCHEMBL15946376

SCHEMBL15946376

CNC(=N)NC(=N)NCCCC(C)C

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KISS1R Q969F8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20061189 0.92 LMNA (0.33)
SCHEMBL22507527 0.90 KISS1R (0.32) KISS1R
SCHEMBL26254720 0.88 ANPEP (0.34)
SCHEMBL19578555 0.83 EPHX1 (0.33)
SCHEMBL28641303 0.81 KDM4E (0.37)
SCHEMBL20275297 0.80 MEN1 (0.31)
SCHEMBL13227081 0.78 EPHX1 (0.39)
SCHEMBL16563018 0.77 ANPEP (0.37)
SCHEMBL20799751 0.76 MEN1 (0.32)
SCHEMBL22507534 0.76 EPHX1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014123364-A1 N1-CYCLIC AMINE-N5-SUBSTITUTED BIGUANIDE DERIVATIVES, METHODS OF PREPARING THE SAME AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME HANALL BIOPHARMA CO., LTD. (KR) 2014-08-14 WO disclosed